Kidney Disease: The Silent Killer | Golden Age

Kidney disease, affecting over 37 million people in the United States alone, is a complex and multifaceted condition that can lead to end-stage renal disease (ESRD) and even death if left untreated. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the prevalence of kidney disease has increased by 15% since 2015, with diabetes and hypertension being the leading causes. The economic burden of kidney disease is staggering, with estimated annual costs exceeding $130 billion. Despite advances in medical technology, including dialysis and kidney transplantation, the prognosis for patients with kidney disease remains grim, with a 5-year survival rate of only 35% for those on dialysis. Researchers, such as Dr. Joseph V. Bonventre, are working to develop new treatments, including regenerative medicine and gene therapy, to combat this debilitating disease. As the global population ages, the incidence of kidney disease is expected to rise, making it essential to develop effective prevention and treatment strategies to mitigate its impact.